Last updated on May 14, 2020
Compliance with the new EPA Pharmaceutical Rule, “Management Standards of Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” begins with a two-step process.
Read More
Last updated on October 28, 2019
The EPA’s recently finalized Pharmaceutical Rule is effective on August 21, 2019 – six months after being published in the Federal Register. This final rule, referred to as Subpart P, and titled “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” is a sector-based rule for the healthcare industry.
Read More
Last updated on September 22, 2021
P-listed waste, or “acutely toxic” waste, is formally defined by the EPA as “pure and commercial grade formulations of certain unused chemicals that are being disposed.” To meet this definition, the unused chemical must be listed under 40 CFR 261.33 and be part of a commercial chemical product, such as a medication.
Last updated on October 28, 2020
The Environmental Protection Agency’s (EPA) long-awaited final rule for managing hazardous waste pharmaceuticals generated by healthcare facilities was finalized and published in the Federal Register on February 22, 2019. This rule had its origins in the EPA’s 2008 Universal Waste proposal for pharmaceutical waste – and perhaps even earlier based on comments to the EPA from retailers.
Last updated on January 19, 2021
Your house probably contains hazardous waste. Don’t put it in your garbage.